Efficacy and safety of a saquinavir based regimen in HIV-1 infected Thai patients who have chronic IDV [indinavir] associated nephrotoxicity.
Phase of Trial: Phase II
Latest Information Update: 24 Feb 2016
At a glance
- Drugs Saquinavir (Primary) ; Non-nucleoside reverse transcriptase inhibitors; Nucleoside reverse transcriptase inhibitors; Ritonavir
- Indications HIV-1 infections
- Focus Therapeutic Use
- 04 Jun 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jul 2007 New trial record.